TREND WATCH

摘要

The US Food and Drug Administration (FDA) approved 35 new drugs in the fiscal year 2012, the same number as in 2011 (see chart). Half of the drugs were authorized through programmes designed to accelerate the process - for example, in cases of serious unmet medical need involving life-threatening diseases.